e-Drug3D 138 |
METHOXSALEN
|
cas 298-81-7 |
CLASS ANTINEOPLASTIC AGENTS |
ROUTE (list) ORAL TOPICAL INJECTION |
NATURAL MOLECULE (link) | PK parameters Tmax 1.8 HOUR |
Target TARGET DNA PDB Ligand code = 8MO (link to the list of PDB complexes) Download experimental 3D coordinates of 8MO with added hydrogens |
DrugCentral Unknown |
Download SDF file | 9-methoxyfuro[3,2-g]chromen-7-one Formula: Calculated chemical properties: MW 216.18 NB_atoms 16 XLogP 2.55 PSA 49.164 NB_HD 0 NB_HA 4 fsp3 0.08 Lipinski(0=no;1=yes) 1 |
FDA NDA 087781 (pdf not found) INN (METHOXSALEN) METHOXSALEN (ANI PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED NDA 009048 (label) INN (METHOXSALEN) 8-MOP (VALEANT PHARM INTL) APPROVAL= AP YEAR= 1954 DISCONTINUED NDA 019600 (label) INN (METHOXSALEN) OXSORALEN-ULTRA (BAUSCH) APPROVAL= AP YEAR= 1986 NDA 020969 (label) INN (METHOXSALEN) UVADEX (THERAKOS DEVELOPMENT) APPROVAL= AP YEAR= 1999 NDA 202687 (pdf not found) INN (METHOXSALEN) METHOXSALEN (ONESOURCE SPECIALTY) APPROVAL= AP YEAR= 2014 NDA 202603 (pdf not found) INN (METHOXSALEN) METHOXSALEN (ACTAVIS INC) APPROVAL= AP YEAR= 2015 DISCONTINUED |
Other links: |